Positron Corporation (POSC)
OTCMKTS · Delayed Price · Currency is USD
1.470
-0.040 (-2.65%)
Dec 26, 2025, 3:19 PM EST
Positron Market Cap
Positron has a market cap or net worth of $47.11 million as of December 26, 2025. Its market cap has increased by 83.74% in one year.
Market Cap
47.11M
Enterprise Value
47.24M
Revenue
486.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.47
Market Cap Chart
Since December 3, 1993, Positron's market cap has increased from 22.73M to 47.11M, an increase of 107.24%. That is a compound annual growth rate of 2.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 47.11M | 70.81% |
| Dec 30, 2024 | 27.58M | -29.54% |
| Dec 29, 2023 | 39.14M | 88.62% |
| Dec 29, 2022 | 20.75M | -34.40% |
| Dec 31, 2021 | 31.63M | 1,169.21% |
| Dec 31, 2020 | 2.49M | 42.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 730.42M |
| Elite Pharmaceuticals | 515.58M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 390.29M |
| CytoDyn | 359.24M |
| Silence Therapeutics | 296.16M |
| Nika Pharmaceuticals | 291.10M |